TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 68 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $28,000 | +21.7% | 20,583 | 0.0% | 0.00% | – |
| Q4 2018 | $23,000 | -59.6% | 20,583 | 0.0% | 0.00% | – |
| Q3 2018 | $57,000 | -21.9% | 20,583 | 0.0% | 0.00% | – |
| Q2 2018 | $73,000 | +15.9% | 20,583 | 0.0% | 0.00% | – |
| Q1 2018 | $63,000 | -51.5% | 20,583 | 0.0% | 0.00% | – |
| Q4 2017 | $130,000 | -7.8% | 20,583 | 0.0% | 0.00% | – |
| Q3 2017 | $141,000 | -4.1% | 20,583 | 0.0% | 0.00% | – |
| Q2 2017 | $147,000 | -8.7% | 20,583 | +17.8% | 0.00% | – |
| Q1 2017 | $161,000 | +130.0% | 17,479 | 0.0% | 0.00% | – |
| Q4 2016 | $70,000 | +4.5% | 17,479 | 0.0% | 0.00% | – |
| Q3 2016 | $67,000 | -10.7% | 17,479 | 0.0% | 0.00% | – |
| Q2 2016 | $75,000 | -7.4% | 17,479 | 0.0% | 0.00% | – |
| Q1 2016 | $81,000 | -53.7% | 17,479 | 0.0% | 0.00% | – |
| Q4 2015 | $175,000 | +34.6% | 17,479 | 0.0% | 0.00% | – |
| Q3 2015 | $130,000 | -99.4% | 17,479 | -96.0% | 0.00% | -100.0% |
| Q2 2015 | $20,610,000 | +119.8% | 434,454 | +69.8% | 0.05% | +123.8% |
| Q1 2015 | $9,375,000 | +1297.2% | 255,846 | +1414.9% | 0.02% | +2000.0% |
| Q4 2014 | $671,000 | +99.1% | 16,889 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $337,000 | +47.8% | 16,889 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $228,000 | – | 16,889 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 293,675 | $14,061,000 | 4.76% |
| BB BIOTECH AG | 1,507,114 | $71,497,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 893,076 | $42,368,000 | 1.77% |
| Opaleye Management Inc. | 65,000 | $3,084,000 | 1.23% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 390,294 | $18,515,000 | 1.14% |
| Granite Point Capital Management, L.P. | 75,206 | $3,568,000 | 1.04% |
| Granahan Investment Management | 705,601 | $33,474,000 | 0.95% |
| Iguana Healthcare Management, LLC | 50,000 | $2,372,000 | 0.75% |
| Eventide Asset Management | 290,000 | $13,758,000 | 0.74% |
| Rhenman & Partners Asset Management AB | 107,400 | $5,095,000 | 0.61% |